InvestorsHub Logo
icon url

Drugdoctor

09/14/07 8:21 AM

#1219 RE: SPICEMIKE #1217

This statement from the 10Q Earnings Report says it all.

I'm surprised they didn't add this statement from the 10Q SEC filing to their press release..

The Company is encouraged by recent sales gains and reductions in its operating shortfall of gross margin to selling, general and administrative expenses. Under favorable sales, cost and expense projections, the Company anticipates its operations may become cash-flow neutral by the end of the first quarter of fiscal 2008.

Looks like the COPI story is heating up!

As to how high it could go...

The market cap of the company is 700,000 dollars right now, and with revenues of 2 million dollars per year, and almost profitable...

To get the market cap just to revenues for 1 year would be a price of .03 per share and 2 x revenues, which is a reasonable price to revenues ratio, would be a .06 price...

So if you want targets.. Target 1 is .03 and target 2 is .06 based on revenues...

If you factor in a premium for growth rate and future profits.. Way higher...

Let's get back to .02's first :-)

GLTA